Journal
VACCINES
Volume 4, Issue 2, Pages -Publisher
MDPI
DOI: 10.3390/vaccines4020015
Keywords
group B streptococcus; Streptococcus agalactiae; capsular polysaccharide; antigen; mimotope; synthetic peptide
Categories
Funding
- Children's Hospital of New Orleans
- NIH [R01AI42184, R43AI51086, U54GM104940]
- Royal Thai Government
Ask authors/readers for more resources
We have conjugated the S9 peptide, a mimic of the group B streptococcal type III capsular polysaccharide, to different carriers in an effort to elicit an optimal immune response. As carriers, we utilized the soluble protein keyhole limpet hemocyanin and virus-like particles (VLPs) from two plant viruses, Cowpea Chlorotic Mottle Virus and Cowpea Mosaic Virus. We have found that coupling the peptide to the soluble protein elicits a Th2 immune response, as evidenced by the production of the peptide-specific IgG1 antibody and IL-4/IL-10 production in response to antigen stimulation, whereas the peptide conjugated to VLPs elicited a Th1 response (IgG2a, IFN-). Because the VLPs used as carriers package RNA during the assembly process, we hypothesize that this effect may result from the presence of nucleic acid in the immunogen, which affects the Th1/Th2 polarity of the response.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available